Impact of Recombinant Bovine Somatotropin on Bovine Milk Composition and Fatty Acidome: A Multidose Longitudinal Study
- PMID: 36360090
- PMCID: PMC9657729
- DOI: 10.3390/foods11213477
Impact of Recombinant Bovine Somatotropin on Bovine Milk Composition and Fatty Acidome: A Multidose Longitudinal Study
Abstract
Somatotropin is a species-specific polypeptide hormone produced in the pituitary gland of vertebrates. When administered exogenously to cattle, it can increase milk yield. However, the trade and administration of recombinant bovine somatotropin (rbST) to farm animals have been banned in the European Union (EU). Aside from food safety issues, very little is known about the effects of this hormone on milk composition and quality. In this work, a wide profile of fatty acids (the so-called fatty acidome) was determined by GC-FID in raw milk collected from control and rbST-treated lactating cows in a multidose longitudinal study. Milk composition (lactose, protein, fat, dry matter), including minerals (Ca, K, Mg, Na, P), was also determined, and milk yield was recorded. A tendency toward a less saturated profile was observed in the milk collected from animals treated with rbST, with higher concentrations of monounsaturated fatty acids. In addition, less calcium and potassium and more lactose and protein content were observed in milk from treated animals than in regular milk. As a result of this multicomponent profiling of milk, a clear impact of somatotropin treatment on milk quality was observed. The obtained results should be particularly interesting for those countries that permit the use of this hormone in dairy production.
Keywords: bovine; composition; fatty acid; milk; minerals; quality; rbST; somatotropin.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures


Similar articles
-
Lactation performance of Holstein cows treated with 2 formulations of recombinant bovine somatotropin in a large commercial dairy herd in Brazil.J Dairy Sci. 2017 Jul;100(7):5945-5956. doi: 10.3168/jds.2016-11965. Epub 2017 Apr 27. J Dairy Sci. 2017. PMID: 28457552
-
Effects of recombinant bovine somatotropin (rbST) and season on plasma and milk insulin-like growth factors I (IGF-I) and II (IGF-II) in lactating dairy cows.Domest Anim Endocrinol. 2008 Jul;35(1):16-23. doi: 10.1016/j.domaniend.2008.01.003. Epub 2008 Feb 13. Domest Anim Endocrinol. 2008. PMID: 18325721 Clinical Trial.
-
Somatotropin increases plasma ceramide in relation to enhanced milk yield in cows.Domest Anim Endocrinol. 2021 Jan;74:106480. doi: 10.1016/j.domaniend.2020.106480. Epub 2020 Apr 22. Domest Anim Endocrinol. 2021. PMID: 32615506
-
Meta-analysis of the effects of sometribove zinc suspension on the production and health of lactating dairy cows.J Am Vet Med Assoc. 2014 Sep 1;245(5):550-64. doi: 10.2460/javma.245.5.550. J Am Vet Med Assoc. 2014. PMID: 25148097 Review.
-
Recombinant bovine somatotropin's effects on patterns of nutrient utilization in lactating dairy cows.Am J Clin Nutr. 1993 Aug;58(2 Suppl):282S-286S. doi: 10.1093/ajcn/58.2.282S. Am J Clin Nutr. 1993. PMID: 8328401 Review.
Cited by
-
miRNome Characterization of Milk-Derived Extracellular Vesicles in Recombinant Somatotropin-Treated Dairy Cows.Int J Mol Sci. 2025 Mar 8;26(6):2437. doi: 10.3390/ijms26062437. Int J Mol Sci. 2025. PMID: 40141081 Free PMC article.
References
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous